SciDev Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

SciDev heeft een totaal eigen vermogen van A$50.2M en een totale schuld van A$0.0, wat de schuld-eigenvermogensverhouding op 0% brengt. De totale activa en totale passiva bedragen respectievelijk A$72.0M en A$21.8M. De EBIT SciDev is A$4.8M waardoor de rentedekking 7.3 is. Het heeft contanten en kortetermijnbeleggingen van A$9.4M.

Belangrijke informatie

Verhouding schuld/eigen vermogen

AU$0

Schuld

Rente dekkingsratio	7.3x
Contant	AU$9.43m
Aandelen	AU$50.24m
Totaal verplichtingen	AU$21.78m
Totaal activa	AU$72.01m

Recente financiële gezondheidsupdates

Recent updates

The Return Trends At SciDev (ASX:SDV) Look Promising

Nov 13

Improved Revenues Required Before SciDev Limited (ASX:SDV) Stock's 27% Jump Looks Justified

Sep 30

SciDev Limited's (ASX:SDV) Share Price Is Matching Sentiment Around Its Revenues

Dec 22

Downgrade: What You Need To Know About The Latest SciDev Limited (ASX:SDV) Forecasts

Nov 16

There's Been No Shortage Of Growth Recently For SciDev's (ASX:SDV) Returns On Capital

Oct 25

When Should You Buy SciDev Limited (ASX:SDV)?

May 18

SciDev Limited (ASX:SDV) Stocks Pounded By 30% But Not Lagging Market On Growth Or Pricing

Mar 06

There's Been No Shortage Of Growth Recently For SciDev's (ASX:SDV) Returns On Capital

Feb 28

Analysts Just Published A Bright New Outlook For SciDev Limited's (ASX:SDV)

Oct 28

Why SciDev Limited (ASX:SDV) Could Be Worth Watching

Jun 09

Investors Will Want SciDev's (ASX:SDV) Growth In ROCE To Persist

Feb 02

SciDev's (ASX:SDV) Promising Earnings May Rest On Soft Foundations

Sep 07

Have Insiders Been Buying SciDev Limited (ASX:SDV) Shares?

Feb 01

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( A$30.0M ) SDV } overtreffen de korte termijn passiva ( A$20.1M ).

Langlopende schulden: De kortetermijnactiva SDV ( A$30.0M ) overtreffen de langetermijnschulden ( A$1.6M ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: SDV is schuldenvrij.

Schuld verminderen: SDV had 5 jaar geleden geen schulden.

Schuldendekking: SDV heeft geen schulden en hoeft daarom niet gedekt te worden door de operationele kasstroom.

Rentedekking: SDV heeft geen schulden, dus de dekking van rentebetalingen is geen probleem.

SciDev Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Belangrijke informatie

Recente financiële gezondheidsupdates

SciDev Limited Ordinary Shares to Be Deleted from Other OTC

Recent updates

The Return Trends At SciDev (ASX:SDV) Look Promising

Improved Revenues Required Before SciDev Limited (ASX:SDV) Stock's 27% Jump Looks Justified

SciDev Limited, Annual General Meeting, Nov 21, 2024

Full year 2024 earnings: EPS misses analyst expectations

The Return Trends At SciDev (ASX:SDV) Look Promising

SciDev Limited (ASX:SDV) Surges 73% Yet Its Low P/S Is No Reason For Excitement

Price target increased by 29% to AU$0.54

First half 2024 earnings released: EPS: AU$0 (vs AU$0 in 1H 2023)

SciDev (ASX:SDV) Is Looking To Continue Growing Its Returns On Capital

SciDev Limited's (ASX:SDV) Share Price Is Matching Sentiment Around Its Revenues

Downgrade: What You Need To Know About The Latest SciDev Limited (ASX:SDV) Forecasts

There's Been No Shortage Of Growth Recently For SciDev's (ASX:SDV) Returns On Capital

SciDev Limited, Annual General Meeting, Nov 21, 2023

Full year 2023 earnings: EPS and revenues miss analyst expectations

Price target decreased by 7.4% to AU$0.50

When Should You Buy SciDev Limited (ASX:SDV)?

Consensus EPS estimates fall by 29%

SciDev Limited (ASX:SDV) Stocks Pounded By 30% But Not Lagging Market On Growth Or Pricing

There's Been No Shortage Of Growth Recently For SciDev's (ASX:SDV) Returns On Capital

First half 2023 earnings released: EPS: AU$0 (vs AU$0.014 loss in 1H 2022)

Independent & Non-Executive Director recently bought AU$80k worth of stock

Price target increased to AU$0.52

SciDev Ltd Appoints Seán Halpin as Chief Executive Officer

Analysts Just Published A Bright New Outlook For SciDev Limited's (ASX:SDV)

SciDev Limited, Annual General Meeting, Nov 15, 2022

Full year 2022 earnings released: AU$0.003 loss per share (vs AU$0.023 profit in FY 2021)

Why SciDev Limited (ASX:SDV) Could Be Worth Watching

Price target decreased to AU$0.75

First half 2022 earnings: EPS exceeds analyst expectations

Investors Will Want SciDev's (ASX:SDV) Growth In ROCE To Persist

SciDev Limited Ordinary Shares to Be Deleted from Other OTC

Interim Chief Financial Officer Geoff Stephenson has left the company

Price target decreased to AU$1.01

SciDev's (ASX:SDV) Promising Earnings May Rest On Soft Foundations

Full year 2021 earnings released: EPS AU$0.023 (vs AU$0.007 loss in FY 2020)

High number of new and inexperienced directors

Non-Executive Chairman Trevor Jones has left the company

SciDev Limited (ASX:SDV) completed the acquisition of Business of Haldon Industries.

SciDev Limited Maxiflox Contract with Eramet Subsidiary SLN

New 90-day low: AU$0.65

First half 2021 earnings released: EPS AU$0.003 (vs AU$0.002 loss in 1H 2020)

SciDev Limited Announces Executive Changes

Revenue beats expectations

SciDev Limited Names Dan O'Toole BEng to the Board as an Independent, Non-Executive Director

Have Insiders Been Buying SciDev Limited (ASX:SDV) Shares?

New 90-day low: AU$0.70

SciDev Limited Provides an Update on the Increased Activity Levels Within the US Oil and Gas Sector

MD, CEO & Executive Director exercised options and sold AU$517k worth of stock

New 90-day high: AU$0.90

Non-Executive Chairman recently bought AU$62k worth of stock

Non-Executive Chairman recently bought AU$62k worth of stock

Earnings released

New 90-day high - AU$0.88

SciDev Limited has completed a Follow-on Equity Offering in the amount of AUD 2 million.

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Ontdek gezonde bedrijven